Viatris Inc (VTRS)

Viatris Inc. is a healthcare company whose common stock is listed on NASDAQ under the ticker VTRS. Through its subsidiaries, the company operates across North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, the rest of Asia, Africa, Latin America, and the Middle East. Viatris is organized into four reporting segments: Developed Markets, Greater China, JANZ, and Emerging Markets.

The company develops and markets prescription brand medicines, generics, complex generics, and biosimilars across a range of therapeutic areas, including cardiovascular, central nervous system and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, oncology, and respiratory and allergy. It also provides patient support services such as diagnostic clinics, educational seminars, and digital tools. Viatris sells its products to wholesalers, retailers, institutional pharmacies, mail-order and e-commerce pharmacies, specialty pharmacies, payers, insurers, governments, and institutions. Its portfolio includes brands such as Lyrica, Lipitor, Celebrex, Viagra, Creon, Influvac, Wixela Inhub, EpiPen Auto-Injector, and Breyna. Founded in 1961, Viatris is headquartered in Canonsburg, Pennsylvania.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-VTRS
$23.02
12.6% Upside
Fair
$21.50
5.1% Upside
Fair
Good
November 23, 2026
December 16, 2026
2.3%
March 1, 2027
1.7x
1.6x
23.445 B
35.018 B
36.4%
99.4%
2.3
-91.3%
-347.2%
Valuation • Fair Value

Viatris Inc (NASDAQ-VTRS) Fair Value by Valuation Model

Review the available estimates for Viatris Inc (NASDAQ-VTRS), including DCF Fair Value, DDM Fair Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$23.02

Estimated upside of 12.6% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$31.46

Discounted cash flow valuation reference.

DDM Fair Value

$15.43

Dividend discount model valuation reference.

EPV Fair Value

$11.47

Earnings power value estimate.

Comps Fair Value

$17.76

Comparable-company valuation reference.

Analyst Price Target

$21.50

Analysts imply upside of 5.1%.

How to read these valuation models

Use the 7 available valuation references for Viatris Inc (NASDAQ-VTRS) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Viatris Inc (NASDAQ-VTRS)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

14.727 B

Current operating scale indicator.

Revenue Forecast

14.802 B

Forward revenue estimate.

EBITDA

4.376 B

Current operating profitability reference.

EBITDA Forecast

4.526 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Viatris Inc (NASDAQ-VTRS) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Viatris Inc (NASDAQ-VTRS)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-3.02

No elevated caution signal from this screen.

Altman Z-Score

2.3

Intermediate risk zone.

FCF / Net Income

-347.2%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Viatris Inc (NASDAQ-VTRS). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Viatris Inc (NASDAQ-VTRS)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

March 1, 2027

Days to Earnings

103

Dividend Payment Date

December 16, 2026

Ex-Dividend Date

November 23, 2026

Dividend Yield

2.3%

Current income yield reference.

Payout Ratio

-91.3%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Viatris Inc (NASDAQ-VTRS), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Viatris Inc (NASDAQ-VTRS) Stock Forecast & Technical Outlook

Review Viatris Inc (NASDAQ-VTRS) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Viatris Inc (NASDAQ-VTRS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Viatris Inc (NASDAQ-VTRS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Viatris Inc (NASDAQ-VTRS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Viatris Inc (NASDAQ-VTRS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Viatris Inc (NASDAQ-VTRS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Viatris Inc (NASDAQ-VTRS)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, Viatris Inc (NASDAQ-VTRS) has a Buy consensus, with 6 buy, 4 hold and 0 sell recommendations in the current data set.

Buy 6
Hold 4
Sell 0
FAQ • Fast Investor Answers

Viatris Inc (NASDAQ-VTRS) Stock FAQ

Data-supported answers about Viatris Inc (NASDAQ-VTRS), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$23.02
Estimated upside 12.6%
Valuation Rating
Undervalued
Estimated upside of 12.6%
Analyst Target
$21.50
Implied upside 5.1%
Financial Health
Good
Current financial-health read

The current fair value estimate for Viatris Inc (NASDAQ-VTRS) is $23.02. This implies an estimated upside of 12.6% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 12.6% versus the current market price.

The available analyst price target for Viatris Inc (NASDAQ-VTRS) is $21.50. The analyst target implies estimated upside of 5.1%.

The current financial health read for Viatris Inc (NASDAQ-VTRS) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Viatris Inc (NASDAQ-VTRS) is March 1, 2027.

Based on the current data, dividend yield is 2.3%, ex-dividend date is November 23, 2026, payment date is December 16, 2026.

The current market capitalization listed for Viatris Inc is 23.445 B.

The current enterprise value listed for Viatris Inc is 35.018 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Viatris Inc is NASDAQ-VTRS, and the stock is listed on NASDAQ.

Viatris Inc (NASDAQ-VTRS) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Viatris Inc is 36.4%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Viatris Inc is 99.4%. Free float helps investors understand how much of the share base is available for public trading.